Nihon Kohden (NHNKY) Projected to Post Quarterly Earnings on Wednesday

Nihon Kohden (OTCMKTS:NHNKY) will likely be issuing its results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of $0.06 per share and revenue of $299.9750 million for the quarter.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.10. The firm had revenue of $453.10 million for the quarter, compared to the consensus estimate of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. On average, analysts expect Nihon Kohden to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Nihon Kohden Stock Down 0.3%

Shares of Nihon Kohden stock opened at $9.89 on Tuesday. The company has a 50 day moving average price of $9.08 and a 200 day moving average price of $9.80. The firm has a market capitalization of $1.66 billion, a P/E ratio of 16.76 and a beta of 0.37. Nihon Kohden has a 52 week low of $8.12 and a 52 week high of $14.21.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Nihon Kohden has a consensus rating of “Buy”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.